UBS Knock-Out AZN/ DE000UP47PZ7 /
2024-11-07 9:48:12 AM | Chg.-0.220 | Bid9:19:27 PM | Ask9:19:27 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.700EUR | -23.91% | 0.760 Bid Size: 20,000 |
0.770 Ask Size: 20,000 |
AstraZeneca PLC | 56.884 USD | 2078-12-31 | Call |
GlobeNewswire
08-13
Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
06-20
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire
05-15
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
05-13
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-08
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
04-01
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire
03-25
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, In...
GlobeNewswire
03-25
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
GlobeNewswire
03-19
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
GlobeNewswire
03-15
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...